July 19, 2010 – CIVCO’s new RFSuite is designed with the capability to support the requirements set out by the Radiation Therapy Readiness Check Initiative, which was recently presented to the U.S. Food and Drug Administration by the Medical Imaging Technology Association (MITA).

Designed to implement additional patient protection features, the plan encourages clinicians to confirm the correct patient is being treated, the correct treatment plan is delivered as intended and the radiation therapy accessories and patient are positioned correctly prior to treatment. CIVCO’s RFSuite system will work in conjunction with this plan by confirming patient identity and verifying therapy accessories, thereby providing technologists, physicists and physicians with additional checkpoints to enable accurate and safe radiation therapy procedures.

RFSuite and other CIVCO solutions are providing the clinical community with the tools needed to address the new regulations and requirements designed to enhance safety and ensure the effective delivery of radiation therapy. RFSuite’s “hands free” design will also enhance the efficiency of the treatment verification process.

Radiation therapy is a crucial element in the effective treatment of cancer and is responsible for curing millions of patients worldwide. Over the past year, a number of radiation therapy mistreatments have occurred both in the United States and abroad, motivating government agencies to provide new safety recommendations. The Joint Commission (JCAHO) and the Code of Federal Regulations (42 CFR 482 Sec. 482.21) require the hospital to develop, implement and maintain an effective, ongoing, hospital-wide, data-driven quality assessment and performance improvement program. RFSuite is a unique and innovative way to ensure the safe and effective delivery of radiation therapy to millions of patients each year.


Related Content

News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
Subscribe Now